US drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough." Researchers have
Similar stories
4 outlets
See how this story developed, hour by hour
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
19.08.2026
Experimental mRNA drug makes breakthrough in deadly skin cancer treatment
independent.co.uk
19.08.2026
Vaccine breakthrough stops cancer returning in trial
bbc.co.uk
19.08.2026
Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.
finance.yahoo.com
19.08.2026
Related stories
Dolly Parton’s Death Prompts Rare Bipartisan Outpouring From U.S. Political Leaders
California couple heads to Texas court in custody battle with surrogate
The US fall foliage forecast is out. Here’s where to see the most vibrant colors this year
Oil prices tumble amid renewed optimism over the Strait of Hormuz
La Tomatina: More than 20,000 people paint Spanish town red with tomatoes
Tornado wreaks havoc in village in southwestern France